Combination therapy to checkmate Glioblastoma: clinical challenges and advances

Combination therapy is increasingly becoming the cornerstone of current day antitumor therapy. Glioblastoma multiforme is an aggressive brain tumor with a dismal median survival post diagnosis and a high rate of disease recurrence. The poor prognosis can be attributed to unique treatment limitations...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghosh, Debarati, Nandi, Saikat, Bhattacharjee, Sonali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191404/
https://www.ncbi.nlm.nih.gov/pubmed/30327965
http://dx.doi.org/10.1186/s40169-018-0211-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191404/
https://www.ncbi.nlm.nih.gov/pubmed/30327965
http://dx.doi.org/10.1186/s40169-018-0211-8

Ejemplares similares